From the Vascular Biology and Hypertension Program (M.S., T.D., S.O., D.A.C.), University of Alabama at Birmingham.
Division of Nephrology (E.K.J.), University of Alabama at Birmingham.
Hypertension. 2019 Sep;74(3):652-659. doi: 10.1161/HYPERTENSIONAHA.119.13258. Epub 2019 Jul 22.
Masked uncontrolled hypertension (MUCH) in treated hypertensive patients is defined as controlled automated office blood pressure (BP; <135/85 mm Hg) in-clinic but uncontrolled out-of-clinic BP by ambulatory BP monitoring (awake [daytime] readings ≥135/85 mm Hg or 24-hour readings ≥130/80 mm Hg). To determine whether MUCH is attributable to antihypertensive medication nonadherence. One hundred eighty-four enrolled patients were confirmed to have controlled office BP; of these, 167 patients were with adequate 24-hour ambulatory BP recordings. Of 167 patients, 86 were controlled by in-clinic BP assessment but had uncontrolled ambulatory awake BP, indicative of MUCH. The remaining 81 had controlled in-clinic and ambulatory awake BP, consistent with true controlled hypertension. After exclusion of 9 patients with missing 24-hour urine collections, antihypertensive medication adherence was determined based on the detection of urinary drugs or drug metabolites by high-performance liquid chromatography-tandem mass spectrometry. Of the 81 patients with MUCH, 69 (85.2%) were fully adherent and 12 (14.8%) were partially adherent (fewer medications detected than prescribed). Of the 77 patients with true controlled hypertension, 69 (89.6%) were fully adherent with prescribed antihypertensive medications and 8 (10.4%) were partially adherent. None of the patients in either group were fully nonadherent. There was no statistically significant difference in complete or partial adherence between the MUCH and true controlled groups (P=0.403). Measurement of urinary drug and drug metabolite levels demonstrates a similarly high level of antihypertensive medication adherence in both MUCH and truly controlled hypertensive patients. These findings indicate that MUCH is not attributable to antihypertensive medication nonadherence.
经治疗的高血压患者中,隐匿性未控制高血压(MUCH)定义为诊室自动血压监测(BP;<135/85mmHg)控制,但动态血压监测(觉醒[白天]读数≥135/85mmHg 或 24 小时读数≥130/80mmHg)显示血压未控制。为确定 MUCH 是否归因于降压药物治疗不依从。184 名入组患者经证实诊室 BP 得到控制;其中,167 名患者 24 小时动态血压监测记录完整。在 167 名患者中,86 名患者经诊室 BP 评估得到控制,但觉醒时动态 BP 未控制,提示 MUCH。其余 81 名患者诊室和觉醒时动态 BP 均得到控制,与真正的控制高血压一致。排除 9 例 24 小时尿液收集缺失患者后,根据高效液相色谱-串联质谱法检测尿液药物或药物代谢物确定降压药物治疗依从性。在 81 例 MUCH 患者中,69 例(85.2%)完全依从,12 例(14.8%)部分依从(检测到的药物少于规定的药物)。在 77 例真正控制高血压的患者中,69 例(89.6%)完全依从规定的降压药物,8 例(10.4%)部分依从。两组患者均无完全不依从者。在 MUCH 和真正控制组中,完全或部分依从之间无统计学差异(P=0.403)。尿液药物和药物代谢物水平的测量表明,MUCH 和真正控制高血压患者的降压药物治疗依从性水平相似较高。这些发现表明,MUCH 并非归因于降压药物治疗不依从。